Baxter enters $2.2B amended revolving credit facility and $645M term loan amendment

BAXTER INTERNATIONAL INC

New $2.2B revolver matures June 2030, replacing $2.0B facility and terminating €200M euro facility.
Term loan of $645M extended to December 2027, proceeds used to prepay existing term loan in full.
Revolver adds Baxter Healthcare SA and Baxter World Trade SRL as euro borrowers; up to $300M sublimit for euro borrowings.
Option to increase aggregate commitments by up to $1.1B to $3.3B total.
Covenants include net leverage ratio; interest rates vary by currency and credit rating.

item 1.01item 1.02item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.